White Blood Cell-Boosting Drugs Investigated By FDA As Treatments For Nuclear Radiation Exposure
She declined to comment on whether Amgen planned to participate in any future trials of Neupogen or Neulasta as treatments
white blood cell boosting drug investigate fda treatments nuclear radiation exposure decline comment amgen plan participate future trial neupogen neulasta treatment